Study of BGM0504 injection for weight loss
Part of Hormones & metabolism clinical trials.
This study tests a new weekly injection (BGM0504) to help people with obesity or overweight lose weight. It may be an option if you have not had success with diet and exercise alone and meet certain health criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have a BMI of 28 or higher, or a BMI between 24 and 28 with a weight-related health issue (like prediabetes, high blood pressure, or joint pain).
- Your weight has been stable (within 5%) for the past 3 months with diet and exercise.
- You are not pregnant or breastfeeding, and you use effective birth control if needed.
- You do not have diabetes, a history of pancreatitis, or untreated thyroid problems.
- You have not taken weight-loss or GLP-1 medications (like Ozempic) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This trial tests an investigational drug called BGM1812 given as an injection. It is for healthy Chinese adults who are either at a normal weight or are overweight/obese but not diabetic. The study will see how the drug works in the body and check for side effects.
This trial tests a new medicine called BGM0504 to help people with obesity lose weight. It may be an option if diet and exercise have not been enough and you qualify for a treatment study.
This trial tests a new medication called BGM0504 for people with type 2 diabetes that is not well managed with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
This trial tests BGM0504 tablets for weight loss in overweight or obese Chinese adults who do not have diabetes. It checks if the pills are safe and effective for helping you lose weight when paired with diet and exercise.
This study tests a new injection (UBT251) to help people lose weight and improve weight-related health problems. You may qualify if you're overweight or obese and have tried diet and exercise for at least 3 months without much success.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.